Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)
China flag China · Delayed Price · Currency is CNY
75.25
+0.47 (0.63%)
Nov 13, 2024, 3:00 PM CST

Beijing Wantai Biological Pharmacy Enterprise Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
2,5333,8195,1931,416710.67283.99
Upgrade
Short-Term Investments
650400-20052.545
Upgrade
Trading Asset Securities
2,3172,0552,00940.3950.3658
Upgrade
Cash & Short-Term Investments
5,5006,2747,2011,656813.57346.99
Upgrade
Cash Growth
-3.78%-12.88%334.83%103.56%134.46%-18.81%
Upgrade
Accounts Receivable
2,4652,9993,9602,277711.6261.39
Upgrade
Other Receivables
27.1748.715.1512.4513.040.5
Upgrade
Receivables
2,4923,0533,9702,292724.64264.02
Upgrade
Inventory
846.24905.48869.14593.17400.04236.43
Upgrade
Prepaid Expenses
-----0.16
Upgrade
Other Current Assets
148.9569.42139.4105.239.5438.05
Upgrade
Total Current Assets
8,98810,30212,1804,6471,978885.66
Upgrade
Property, Plant & Equipment
3,2552,6412,2351,703790.98627.7
Upgrade
Long-Term Investments
1,1311,432911.361.3211.3228.5
Upgrade
Other Intangible Assets
517.11507.24289.37289.92226.66232.67
Upgrade
Long-Term Deferred Tax Assets
159.32157.9566.0168.9756.4993.69
Upgrade
Long-Term Deferred Charges
240.41215.33175.4927.1827.7627.05
Upgrade
Other Long-Term Assets
449.75459.41372.3249.09212.769.65
Upgrade
Total Assets
14,73915,71516,2307,0463,5042,165
Upgrade
Accounts Payable
430.38234.28275.47154.08107.2985.05
Upgrade
Accrued Expenses
156.611,6532,5721,541440.8147.66
Upgrade
Short-Term Debt
97.6481.14140.14235.6477.66-
Upgrade
Current Portion of Long-Term Debt
33.1487.193.07---
Upgrade
Current Portion of Leases
-13.313.7313.93--
Upgrade
Current Income Taxes Payable
21.957.4999.02146.554.377.84
Upgrade
Current Unearned Revenue
39.8370.3882.2870.340.92-
Upgrade
Other Current Liabilities
1,170523.42299.34204.64157.98251.48
Upgrade
Total Current Liabilities
1,9492,6703,4852,366829.03492.03
Upgrade
Long-Term Debt
136.25115.36102.494.9-21
Upgrade
Long-Term Leases
11.3812.3618.4332.59--
Upgrade
Long-Term Unearned Revenue
33.2933.6541.3776.4494.2671.16
Upgrade
Long-Term Deferred Tax Liabilities
--17.15---
Upgrade
Other Long-Term Liabilities
---3.8--
Upgrade
Total Liabilities
2,1302,8313,6652,483923.29584.19
Upgrade
Common Stock
1,2651,268906.07607.04433.6390
Upgrade
Additional Paid-In Capital
3,1393,3123,729445.83446.27172.02
Upgrade
Retained Earnings
8,1118,2507,9063,4131,674996.8
Upgrade
Treasury Stock
-92.17-129.42-200.17---
Upgrade
Total Common Equity
12,42312,70112,3414,4662,5541,559
Upgrade
Minority Interest
186.14183.06223.6396.226.7321.91
Upgrade
Shareholders' Equity
12,60912,88412,5654,5622,5801,581
Upgrade
Total Liabilities & Equity
14,73915,71516,2307,0463,5042,165
Upgrade
Total Debt
278.41309.35277.86287.0677.6621
Upgrade
Net Cash (Debt)
5,2225,9656,9231,369735.91325.99
Upgrade
Net Cash Growth
-4.01%-13.85%405.71%86.03%125.74%-19.78%
Upgrade
Net Cash Per Share
4.134.735.541.110.620.30
Upgrade
Filing Date Shares Outstanding
1,3291,2681,2681,2321,2321,108
Upgrade
Total Common Shares Outstanding
1,3291,2681,2681,2321,2321,108
Upgrade
Working Capital
7,0387,6328,6952,2811,149393.63
Upgrade
Book Value Per Share
9.3510.019.733.622.071.41
Upgrade
Tangible Book Value
11,90612,19312,0524,1762,3271,326
Upgrade
Tangible Book Value Per Share
8.969.619.503.391.891.20
Upgrade
Buildings
-724.87628.89392.67253.3246.27
Upgrade
Machinery
-1,5101,185666.87565.97490.03
Upgrade
Construction In Progress
-814.56720.51924.38231.581.68
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.